Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
6(33%)
Results Posted
0%(0 trials)
Terminated
1(6%)

Phase Distribution

Ph phase_2
2
11%
Ph not_applicable
1
6%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

6

trials recruiting

Total Trials

18

all time

Status Distribution
Active(8)
Completed(6)
Terminated(1)
Other(3)

Detailed Status

Completed6
Recruiting3
Active, not recruiting3
unknown3
Enrolling by invitation1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
6
Success Rate
85.7%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (66.7%)
N/A1 (33.3%)

Trials by Status

enrolling_by_invitation16%
not_yet_recruiting16%
recruiting317%
completed633%
active_not_recruiting317%
unknown317%
terminated16%

Recent Activity

6 active trials
Showing 5 of 18
active_not_recruitingnot_applicable

Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study)

NCT04967807
recruitingphase_2

Using Xe MRI to Guide Radiation Therapy for Lung Cancer

NCT06925295
not_yet_recruiting

Delirium and Heart Failure

NCT07302737
completed

COPD-Related Physiology and the Brain

NCT03269721
completed

Postoperative Neurocognitive Disorders

NCT04244162
View all 18 trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT04967807Not Applicable

Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study)

Active Not Recruiting
NCT06925295Phase 2

Using Xe MRI to Guide Radiation Therapy for Lung Cancer

Recruiting
NCT07302737

Delirium and Heart Failure

Not Yet Recruiting
NCT03269721

COPD-Related Physiology and the Brain

Completed
NCT04244162

Postoperative Neurocognitive Disorders

Completed
NCT05273216

Reperfusion Injury After Endovascular Stroke Treatment

Recruiting
NCT04088773

Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease

Active Not Recruiting
NCT05339451

Blood and Tissue Markers for Improving Diagnosis and Prognosis of Endometriosis. (ENDOBIO)

Recruiting
NCT06207708

Sarcopenia in Head and Neck Cancer Patients Treated with Curative Hadrontherapy

Completed
NCT04566562

Blood Brain Barrier Dysfunction and Postoperative Neurocognitive Disorders

Completed
NCT05609201

PRospective Evaluation of Interstitial Lung DIsease Progression With Quantitative CT

Enrolling By Invitation
NCT05183087

Long-Term Effects of Repetitive, Low-Level Blast Exposure on Special Operations Forces Service Members

Completed
NCT04311515Phase 2

To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Dementia

Terminated
NCT01835054

Determinants of the Progression and Outcome of Mitral Regurgitation

Unknown
NCT01835028

Multicenter Prospective Study of Low-Flow Low-Gradient Aortic Stenosis (TOPAS Study)

Unknown
NCT04974320

Rapid Identification of MINOCA Based on Novel Biomarkers

Unknown
NCT03927872

Cardio-embolic Stroke and Blood Bio-markers

Completed
NCT03192410

Prospective Cohort Study of 4,837 Post-myocardial Infarction Patients (Alpha Omega Cohort)

Active Not Recruiting

All 18 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
18